Nova Patents
LU91117I2

Cetuximab in combination with irinotecan.

Abstract

Monoclonal antibodies and hybrid cell lines for production of monoclonal antibodies specific to the human epidermal growth factor receptor which are capable of inhibiting the growth of human tumor cells expressing human epidermal growth factor receptors are provided. Therapeutic compositions containing these monoclonal antibodies by themselves and in combination with anti-neoplastic agents are also disclosed.

Term

Term ended

Projected expiry passed 29 October 2024, 1.9 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

38 members in 10 offices

This recordMember, by publication datePriority claim

Priority claims9

Priority claims
DocumentOfficeKindDate
24473788United States of AmericaA
24473788United States of AmericaA
31910989United States of AmericaA
31910989United States of AmericaA
89117125European Patent Office (EPO)A
89117125European Patent Office (EPO)A
EP19890117125
US19880244737
US19890319109

Members38

Family members, oldest first
DocumentOfficeKind
EP0359282A2European Patent Office (EPO)A2
AU4128089AAustraliaA
EP0359282A3European Patent Office (EPO)A3
JPH02291295AJapanA
EP0359282B1European Patent Office (EPO)B1
AT123070TAustriaT
ATE123070T1AustriaT1
DE68922808D1GermanyD1
EP0667165A1European Patent Office (EPO)A1
DE68922808T2GermanyT2
ES2075019T3SpainT3
CA1340417CCanadaC
US6217866B1United States of AmericaB1
EP0667165B1European Patent Office (EPO)B1
AT214943TAustriaT
ATE214943T1AustriaT1
JP2002114710AJapanA
DE68929384D1GermanyD1
ES2174859T3SpainT3
DE68929384T2GermanyT2
JP3600617B2JapanB2
LU91116I2LuxembourgI2
LU91117I2This recordLuxembourgI2
DE122004000040I1GermanyI1
DE122004000041I1GermanyI1
JP2005047934AJapanA
NL300166I1Netherlands (Kingdom of the)I1
NL300167I1Netherlands (Kingdom of the)I1
JP3732426B2JapanB2
JP4122393B2JapanB2
LU91448I2LuxembourgI2
LU91449I2LuxembourgI2
NL300350I1Netherlands (Kingdom of the)I1
NL300351I1Netherlands (Kingdom of the)I1
NL300353I1Netherlands (Kingdom of the)I1
DE122008000028I1GermanyI1
DE122008000030I1GermanyI1
DE122008000027I1GermanyI1